Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses

Retrovirology

Volumn 11, Issue 1, 2014, Pages

  Marno, Kelly M ^a   Ogunkolade, Babatunji W ^a   Pade, Corinna ^a   Oliveira, Nidia M M ^a   O'Sullivan, Eithne ^a   McKnight, Áine ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; PROTEIN; RESTRICTION FACTOR; RNA ASSOCIATED EARLY STAGE ANTI VIRAL FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CELL INVASION; CONTROLLED STUDY; FOCUS FORMING UNIT ASSAY; GENE SILENCING; GENOME; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RETROVIRUS; REVERSE TRANSCRIPTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENTRY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; SIMIAN IMMUNODEFICIENCY VIRUS;

HIV-1; HIV-2; HUMANS; IMMUNITY, INNATE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INTEGRATION;

EID: 84892422530     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-11-3     Document Type: Article

References (20)

1. Bishop KN, Holmes RK, Sheehy AM, Malim MH. APOBEC-mediated editing of viral RNA. Science 2004, 305:645. 10.1126/science.1100658, 15286366.
2. Descours B, Cribier A, Chable-Bessia C, Ayinde D, Rice G, Crow Y, Yatim A, Schwartz O, Laguette N, Benkirane M. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology 2012, 9:87. 10.1186/1742-4690-9-87, 3494655, 23092122.
3. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012, 13:223-228. 10.1038/ni.2236, 3771401, 22327569.
4. St Gelais C, Wu L. SAMHD1: a new insight into HIV-1 restriction in myeloid cells. Retrovirology 2011, 8:55. 10.1186/1742-4690-8-55, 3142215, 21740548.
5. Bergamaschi A, David A, Le Rouzic E, Nisole S, Barre-Sinoussi F, Pancino G. The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages. J Virol 2009, 83:12253-12265. 10.1128/JVI.01395-09, 2786717, 19759136.
6. Liu L, Oliveira NM, Cheney KM, Pade C, Dreja H, Bergin AM, Borgdorff V, Beach DH, Bishop CL, Dittmar MT, McKnight A. A whole genome screen for HIV restriction factors. Retrovirology 2011, 8:94. 10.1186/1742-4690-8-94, 3228845, 22082156.
7. Allouch A, Di Primio C, Alpi E, Lusic M, Arosio D, Giacca M, Cereseto A. The TRIM family protein KAP1 inhibits HIV-1 integration. Cell Host Microbe 2011, 9:484-495. 10.1016/j.chom.2011.05.004, 21669397.
8. Goff SP. Host factors exploited by retroviruses. Nat Rev Microbiol 2007, 5:253-263. 10.1038/nrmicro1541, 17325726.
9. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430. 10.1038/nature06553, 18200009.
10. Harrison IP, McKnight A. Cellular entry via an actin and clathrin-dependent route is required for Lv2 restriction of HIV-2. Virology 2011, 415:47-55. 10.1016/j.virol.2011.04.001, 21514617.
11. Marchant D, Neil SJ, Aubin K, Schmitz C, McKnight A. An envelope-determined, pH-independent endocytic route of viral entry determines the susceptibility of human immunodeficiency virus type 1 (HIV-1) and HIV-2 to Lv2 restriction. J Virol 2005, 79:9410-9418. 10.1128/JVI.79.15.9410-9418.2005, 1181606, 16014904.
12. Schmitz C, Marchant D, Neil SJ, Aubin K, Reuter S, Dittmar MT, McKnight A. Lv2, a novel postentry restriction, is mediated by both capsid and envelope. J Virol 2004, 78:2006-2016. 10.1128/JVI.78.4.2006-2016.2004, 369432, 14747565.
13. Oliveira NM, Trikha R, McKnight A. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5alpha independent. Retrovirology 2010, 7:81. 10.1186/1742-4690-7-81, 2959036, 20929586.
14. Burdick R, Smith JL, Chaipan C, Friew Y, Chen J, Venkatachari NJ, Delviks-Frankenberry KA, Hu WS, Pathak VK. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. J Virol 2010, 84:10241-10253. 10.1128/JVI.00585-10, 2937795, 20668078.
15. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657. 10.1038/nature10117, 3595993, 21613998.
16. Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem 2004, 279:7792-7798.
17. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650. 10.1038/nature00939, 12167863.
18. Salahuddin SZ, Markham PD, Wong-Staal F, Franchini G, Kalyanaraman VS, Gallo RC. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 1983, 129:51-64. 10.1016/0042-6822(83)90395-1, 6412453.
19. Cheney KM, McKnight A. Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication. PLoS One 2010, 5:e13521. 10.1371/journal.pone.0013521, 2958147, 20975956.
20. McKnight A, Clapham PR, Weiss RA. HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages. Virology 1994, 201:8-18. 10.1006/viro.1994.1260, 8178492.